Journal Information
Vol. 114. Issue 4.
Pages T356-T359 (April 2023)
Share
Share
Download PDF
More article options
Visits
3534
Vol. 114. Issue 4.
Pages T356-T359 (April 2023)
Case and Research Letter
Full text access
Clinicopathologic Correlations in Erythema ab Igne: A Series of 5 Patients and Review of the Literature
Eritema ab igne: correlación clínico-patológica en una serie de 5 pacientes y revisión de la literatura
Visits
3534
N. Segurado Tostóna,
Corresponding author
nestorst_zamora@hotmail.com

Corresponding author.
, L. Puebla Torneroa,b, D. Revilla Nebredaa, A. Santos-Briz Terrónb
a Servicio de Dermatología, Complejo Asistencial Universitario de Salamanca, Spain
b Servicio de Anatomía Patológica, Complejo Asistencial Universitario de Salamanca, Spain
Related content
N. Segurado Tostón, L. Puebla Tornero, D. Revilla Nebreda, A. Santos-Briz Terrón
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Full Text
To the Editor:

Erythema ab igne is recognized by a reticulated pattern of erythema and hyperpigmentation in an area exposed to heat. Initially the lesions are transient, easily blanching macules in a circumscribed area that reflects the size of the heat source. Later, hyperpigmentation becomes fixed; atrophy, hyperkeratosis, and telangiectasia may develop. Although the pathophysiology of these lesions is poorly understood, their appearance suggests an effect of infrared radiation on the venous plexus of the dermis (Fig. 1).

Figure 1.

Reddish-violaceous plaques with tense serosanguineous blisters, tracing a reticular pattern. At the time the photograph was taken, the lesions had been present for only a few days.

(0.1MB).

When the application of heat to alleviate pain is responsible for the lesions, it is important to rule out underlying conditions of which pain might be the first symptom.1,2 Examples are metastasis to the lumbar or sacral spine and musculoskeletal or visceral disease.

Fewer cases of erythema ab igne in recent years have been caused by space heaters, fireplaces, or similar sources of heat by combustion. However, cases are now appearing related to new electrical and electronic devices that emit heat directly or indirectly,3 including laptops,4 blankets, heaters, and heated seats.5 The type of patient who presents with these skin lesions has also changed. Whereas erythema ab igne was originally seen most often in older individuals, it is now relatively common in young or middle-aged persons. Occupations that expose the skin to high temperatures also cause these lesions. When blisters form over erythema ab igne, diabetes mellitus is often present.6

The diagnosis is eminently clinical, requiring careful examination of the skin and a complete medical history in search of the heat source causing the lesions. If both the history and examination are thorough, erythema ab igne is easily recognized. However, patients do not always know the cause, or the lesions may be in atypical locations. In such cases, certain histologic findings in skin biopsies can help orient the diagnosis.7

Differential diagnosis should include livedo reticularis and livedo racemosa, with all their possible causes; dermatomyositis, poikiloderma; livedoid vasculitis; and very rarely, cutaneous T-cell lymphoma.8

The literature offers case reports related to different causes or heat sources, but no large patient series bringing together the various causes of erythema ab igne have been published. Patient series are even less likely to describe histologic features. We present a series of 5 cases and analyze common characteristics.

Case Descriptions

We list the characteristics of 5 patients with clinical and histologic findings consistent with a diagnosis of erythema ab igne (Table 1).

Table 1.

Characteristics of the 5 Patients in the Series.

  Patient 1  Patient 2  Patient 3  Patient 4  Patient 5 
Age, y  67  30  49  62  39 
Sex  Man  Woman  Woman  Man  Woman 
Relevant history  None  None, except oral contraceptives since the age of 23 y  Smoker; hypothyroidism; and alcoholic fatty liver disease, with abnormal liver enzymes since 2018  Type 1 DM (20 y)  None, except COVID-19, 2 mo earlier 
Time since presentation  2 mo  Several months  Years  4 d  5 d 
Acknowledged cause  No  Yes (heater)  Unknown (history taking not possible)  No  No 
Site  Front and inside of the distal third of legs and ankles  Lower part of the right thigh and lower leg, external side of the left thigh and lower leg  Both ankles and pretibial skin  Upper third of the lower portion of the legs (Fig. 1Backs of both legs 
Additional tests  None required  No abnormal findings in general blood parameters, including coagulation factor; ANA and ENA  Serology, imaging, echocardiogram, and blood tests all normal for parameters that would explain the symptoms  None required  Unremarkable serology and blood work-up, including markers for autoimmunity and thrombophilia 

Abbreviations: ANA, antinuclear antibody; DM, diabetes mellitus; ENA, extractable nuclear antigen.

Histopathology

Mild nuclear cellular atypia (discrete enlargement), with edema and an abundance of extravasated erythrocytes were found in the epidermis (Figs. 2 and 3). Hemosiderin was also found in the papillary dermis or occasionally in the stratum corneum. Hyperkeratosis, epidermal atrophy, and apoptotic bodies were other occasional findings, and solar elastosis was present in older patients. We never observed vasculitis in this series, although endothelial swelling was sometimes found.

Figure 2.

Orthokeratotic hyperkeratosis in the stratum corneum, atypia consisting of keratinocytes in the epidermis, and marked extravasation of blood. Mild superficial perivascular infiltrate of lymphocytes and monocytes.

(0.41MB).
Figure 3.

Hyperkeratosis in the stratum corneum, atypia in the epidermis, and extravasated blood and edema in the papillary dermis.

(0.37MB).
Conclusions

In the absence of a complete medical history, or if the patient does not acknowledge exposure to heat, it is very difficult to come to a diagnosis of erythema ab igne. A diagnosis will require additional tests to rule out other diagnoses or skin biopsy findings like those mentioned above. Most of the patients in this series did not acknowledge the cause of the lesions during the first visit.

Treatment invariably involves eliminating the cause by avoiding exposing the skin to direct heat at the level the patient had been accustomed to. Postinflammatory hyperpigmentation, an after effect in most cases, is difficult to treat but may improve with time. The atypia of erythema ab igne, which can resemble the atypia of actinic keratosis, may respond to topical application of retinoids, 5-fluorouracil, or different modalities of laser therapy. Squamous cell carcinoma, marginal B-cell lymphoma, or Merkel cell carcinoma in the affected area has been reported to develop over the long term.4,6 None of the patients in this series presented complications during the time we followed them.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References
[1]
I. Marie.
Erythema ab igne.
Arthritis Rheumatol, 70 (2018), pp. 1896
[2]
I.A. Harsch.
Abdominal erythema ab igne—an “old” finding revisited.
Clin Case Rep, 8 (2020), pp. 1315-1316
[3]
F. Salgado, M.Z. Handler, R.A. Schwartz.
Erythema ab igne: new technology rebounding upon its users?.
Int J Dermatol, 57 (2018), pp. 393-396
[4]
A.W. Arnold, P.H. Itin.
Laptop computer-induced erythema ab igne in a child and review of the literature.
[5]
D. Baltazar, R. Brockman, E. Simpson.
Kotatsu-induced erythema ab igne.
An Bras Dermatol, 94 (2019), pp. 2018-2019
[6]
M. Ozturk, I. An.
Clinical features and etiology of patients with erythema ab igne: a retrospective multicenter study.
J Cosmet Dermatol, 19 (2020), pp. 1774-1779
[7]
D. Weedon.
Weedon's skin pathology.
[8]
K. Beleznay, S. Humphrey, S. Au.
Erythema ab igne.
CMAJ, 182 (2010), pp. 81216
Copyright © 2022. AEDV
Download PDF
Idiomas
Actas Dermo-Sifiliográficas
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?